Skip to main content
. 2014 May-Jun;58(3):281–286. doi: 10.4103/0019-5049.135038

Table 1.

Demographic data, base line variables and indications for CVC in patients receiving dexmedetomidine or placebo

graphic file with name IJA-58-281-g001.jpg